02526.HK
Hangzhou Diagens Biotechnology Co., Ltd.
HKSE · Healthcare · Medical - Devices · CN
HKD 495.60
−1.76%Aug 8, 2026, 05:54 UTC
Desh-B (02526.HK) completed the upgrade of its AI medical platform, transitioning from an AI device manufacturer to an AI platform service provider, leveraging its self-developed iMedImage foundation model and iMedLoop standardized AI production line.
Source:Aug 7, 2026, 08:44 UTC
Hangzhou Desheng Biotech reported interim results for the six months ended June 2026, with revenue of 108.7 million RMB, up 21.0% year-on-year, and a widened net loss of 55.88 million RMB.